
Georgia Cancer Center
@gacancercenter
Georgia’s innovation center for cancer clinical care & research. We unite research & practice to prevent, treat, & ultimately cure cancer illness. RT≠endorse
ID: 750767911288135680
https://linktr.ee/georgiacancercenter 06-07-2016 19:06:33
2,2K Tweet
1,1K Followers
343 Following

It was such a delight to represent Georgia Cancer Center at the Wycliffe Gordon benefit concert this week! Wycliffe Gordon Fanpage



Optimizing multidisciplinary care for metastatic hormone-sensitive #ProstateCancer. Zach Klaassen Georgia Cancer Center joins Pedro C Barata, MD MSc FACP Case Comp Cancer Ctr to discuss optimizing #mHSPC care through treatment intensification + multidisciplinary teamwork. Despite proven benefits, many still


Video in @UroToday: Zach Klaassen of Georgia Cancer Center speaks with Dr. Katharina Oberneder about oncological outcomes in patients undergoing cystectomy after BCG failure. Click to watch the video: urotoday.com/video-lectures…


Watch Jorge Cortes MD of Georgia Cancer Center and Stephen Strickland of Sarah Cannon Docs discuss evaluating response to first-line TKI therapy through regular molecular testing of BCR::ABL1 transcript levels. Watch the full video here: hubs.ly/Q03rxJbP0

The first issue of Blood Global Hematology is out with great hematology research from all other the world. Blood Journals Portfolio ASH Georgia Cancer Center


So good to have ASH increasing support for research. Blood Global Hematology Blood Journals Portfolio Georgia Cancer Center

Mentoring the next generation of #GUOncology leaders. Andrea Apolo, M.D. National Cancer Institute joins Zach Klaassen Georgia Cancer Center to reflect on the inaugural GU Early Thought Leaders Conference — a unique event focused on career growth, not just science. From trial design to work-life balance,

Some considerations on the dosing of TKIs in CML just published in Blood Journals Portfolio. Blood Global Hematology International CML Foundation Georgia Cancer Center doi.org/10.1182/blood.…

Congratulations to our graduating class of Med Onc/Heme Georgia Cancer Center fellows. A great group, here with the fellowship program leadership led by Dr. Locke Bryan. MCG Augusta University


#ARANOTE trial shows benefit of #darolutamide in low-volume #mHSPC. Fred Saad, CQ, MD, FRCS, FCAHS CURC joins Zach Klaassen Georgia Cancer Center discussing a case of a 64-year-old active pilot with #CHAARTED low-volume but #LATITUDE high-risk disease. #WatchNow on UroToday >

Smoking cessation as a precision cancer care intervention in #UrologicOncology. Rich Matulewicz Memorial Sloan Kettering Cancer Center and Zach Klaassen Georgia Cancer Center highlight smoking cessation as a powerful intervention that can increase overall survival by nearly two years in cancer patients.

👏 Congratulations to Lynn Hedrick☀️🌙, who received the 2025 Outstanding Leadership Award at the Georgia Cancer Center Research Retreat! We already know what an incredible leader she is — now the whole campus does, too. #Leadership #CancerResearch #IMMCG 📷


Last Week Mat Swift, a Regent with the University System of Georgia's Board of Regents visited the GCC and Immunology Center of Georgia at Augusta University to learn more about the work going on here at the GCC. Thank you Dr. Russell Keen and Yvonee Turner of Augusta University for joining the visit.


Thank you Regent Mat Swift and President Keen for your visit to Georgia Cancer Center to learn about the great research our faculty are conducting to decrease the burden of cancer in Georgia. Augusta University MCG


Interdisciplinary #GUCancerForum 2025: The role of ctDNA in selecting adjuvant therapy post-cystectomy. Presentation by Gennady Bratslavsky Upstate Medical University. Written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/3ZGbYUc



Evaluation of PSMA PET/CT derived predictors for treatment response to 177Lu-PSMA-617: Results from The U.S. Expanded-Access Program. Presented by Koichiro Kimura, MD UCLA. #SNMMI25 written coverage by Zach Klaassen Georgia Cancer Center > bit.ly/4ndhjwx #SNMMI2025 SNMMI


Improving PSA doubling time calculation for high-risk biochemical recurrence. Alicia Morgans, MD, MPH Dana-Farber, and Zach Klaassen Georgia Cancer Center discuss the impact of PSA doubling time awareness on treatment decisions for high-risk biochemical recurrence. #WatchNow >